Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech 2023-05-22 21:23
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations 2023-05-22 16:30
Oncoclínicas Group records a net revenue of BRL 41 million for Q123 2023-05-22 11:18
One BioMed Announce World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction 2023-05-22 08:00
Laekna announces first IND clearance by U.S. FDA for internally-discovered LAE102 2023-05-21 22:23
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' 2023-05-20 00:55
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 21:00
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease 2023-05-19 19:00
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™) 2023-05-19 16:34
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 16:00
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023 2023-05-18 20:25
DISCOVERY LIFE SCIENCES JOINS AKOYA BIOSCIENCES' GLOBAL SERVICE PROVIDER NETWORK TO ACCELERATE IMMUNO-ONCOLOGY RESEARCH 2023-05-18 20:05
Top-quality medical grade TPUs enabled by smart factory: ICP DAS - BMP to exhibit at Medtec China 2023 2023-05-18 17:02
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer 2023-05-18 16:00
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus 2023-05-18 14:00
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 11:53
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 02:47
Sirnaomics to receive HK$8 million subsidy from the HKSTP Clinical Translational Catalyst Plan 2023-05-17 21:13
Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023 2023-05-17 18:00
1 105 106 107 108 109 452